Pulmatrix prices $15m underwritten public offering

Pulmatrix (NSDQ:PULM) today priced an underwritten public offering of 23,500,000 units, including one share of common stock, one Series A warrant to buy one share of common stock and one Series B warrant to buy one share of common stock per unit. The Lexington, Mass.-based company also gave underwriters a 30-day option to buy an additional 1,150,000 units. Pulmatrix reported that it expects to bring in approximately $15.2 million from the offering. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix prices $15m underwritten public offering appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Funding Roundup Pharmaceuticals Research & Development Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news